Dr. Ronald W. Hart

• 
  www.sec.gov/Archives/edgar/data/924515/0000924515-08-00 - [Cached Version]
  Published on: 11/19/2008    Last Visited: 11/20/2008  

  Ronald W. Hart, Ph.D.
  ...
  Ronald W. Hart, Ph.D. has served as a member of our board of directors since March 2007. He has published over 600 peer-reviewed publications, has been appointed to a number of academic positions and is credited with developing the first direct proof that DNA is causal in certain forms of cancer. He chaired a number of federal committees and task forces, including the development and implementation of the Technology Transfer Act of 1986 and the White House Task Force on Chemical Carcinogenesis. In 1980, Dr. Hart was appointed Director of the National Center for Toxicological Research (NCTR), the research arm of the FDA, a position he held until 1992. In 1992, Dr. Hart was the first ever Presidential Appointee to the position of Distinguished Scientist in Residence for the US Public Health Service/FDA, a position he held until his retirement in 2000. Dr. Hart received his Ph.D. in physiology and biophysics from the University of Illinois. Dr. Hart currently se rves on the boards of directors of Miltos Pharmaceuticals, WaterChef, Inc. (WTER) and SNTech, and since 2002, has helped in the development of business strategy for a number of start-up companies.

• 
  www.sec.gov/Archives/edgar/data/924515/0000924515-09-00 - [Cached Version]
  Published on: 7/28/2009    Last Visited: 7/29/2009  

  Ronald W. Hart, Ph.D.
  ...
  Ronald W. Hart, Ph.D.
  ...
  Ronald W. Hart, Ph.D. has served as a member of our Board of Directors since March 2007. He has published over 600 peer-reviewed publications, has been appointed to a number of academic positions and is credited with developing the first direct proof that DNA is causal in certain forms of cancer. He chaired a number of federal committees and task forces, including the development and implementation of the Technology Transfer Act of 1986 and the White House Task Force on Chemical Carcinogenesis. In 1980, Dr. Hart was appointed Director of the National Center for Toxicological Research, the research arm of the FDA, a position he held until 1992. In 1992, Dr. Hart was the first ever Presidential Appointee to the position of Distinguished Scientist in Residence for the US Public Health Service/FDA, a position he held until his retirement in 2000. Dr. Hart received his Ph.D. in physiology and biophysics from the University of Illinois. Dr. Hart currently serves on the Boards of Director s of Miltos Pharmaceuticals, WaterChef, Inc. and Immunovative, Inc. and since 2002, has helped in the development of business strategy for a number of start-up companies .
  ...
  Based solely on our review of the copies of these forms received by us, we believe that, with respect to fiscal year 2007, our officers, directors, with the exception of directors John Imhoff, M.D., Michael C. James and Ronald Hart who were delinquent in filing their Forms 3, and 10% stockholders were in compliance with all applicable filing requirements.
  ...
  We believe that Mr. James and Dr. Hart are now in compliance.

• 
  www.sec.gov/Archives/edgar/data/924515/0000924515-09-00 - [Cached Version]
  Published on: 5/27/2009    Last Visited: 5/28/2009  

  0001388125 HART RONALD W 4821 CRESTWOOD DRIVE LITTLE ROCK AR 72207 1 0 0 0

• 
  www.sec.gov/Archives/edgar/data/924515/0000924515-07-00 - [Cached Version]
  Published on: 9/25/2007    Last Visited: 9/26/2007  

  Ronald W. Hart, Ph.D
  ...
  Ronald W. Hart, Ph.D. has published over 600 peer-reviewed publications, has been appointed to a number of academic positions and is credited with developing the first direct proof that DNA is causal in certain forms of cancer.He chaired a number of federal committees and task forces, including the development and implementation of the Technology Transfer Act of 1986 and the White House Task Force on Chemical Carcinogenesis.In 1980, Dr. Hart was appointed Director of the National Center for Toxicological Research (NCTR), the research arm of the FDA, a position he held until 1992.In 1992, Dr. Hart was the first ever Presidential Appointee to the position of Distinguished Scientist in Residence for the US Public Health Service/FDA, a position he held until his retirement in 2000.Dr. Hart received his Ph.D. in physiology and biophysics from the University of Illinois.Dr. Hart currently serves on the boards of directors of Miltos Pharmaceuticals, WaterChef, Inc. (WTER) and SNTech, and since 2002, has helped in the development of business strategy for a number of start-up companies.

• 
  www.sec.gov/Archives/edgar/data/764839/0001108890-06-00 - [Cached Version]
  Published on: 3/22/2006    Last Visited: 3/23/2006  

  Ronald W. Hart + Chairman, Scientific Advisory Board
  ...
  Ronald W. Hart (Ph.D.)
  
  Dr. Hart agreed to form the Board of Scientific Advisors in 2000 and became Chairman at that time.Dr. Hart is an internationally recognized scientist and scholar who was Director of the National Center for Toxicological Research and was named "Distinguished Scientist in Residence" by the US Food and Drug Administration in 1992.Recognized for his pioneering work on aging and his studies on nutrition and health, Dr. Hart has been appointed visiting professor at a number of universities, including Cairo University, Seoul National University and Gangzhou University.He received his doctorate in physiology and biophysics from the University of Illinois.

• 
  www.unifiedsignal.com/sitedata/team/ronhart.html - [Cached Version]
  Published on: 6/12/2004    Last Visited: 6/12/2004  

  Ron Hart Advisor
  ...
  Dr. Hart is an internationally recognized scientist and scholar.He has served on the editorial boards of more than a dozen professional journals, as editor of six scientific volumes, and authored or co-authored over 650 scientific publications.Dr. Hart is credited with developing the first direct proof of the pivotal role of DNA damage in certain cancers.He is internationally recognized for his pioneering work in aging and his studies on nutrition and health.As a result of his contributions to science, Dr. Hart received over two dozen national and international awards and recognitions including the Karl-August-Forester-Preis of the German Academy of Science and Literature.He holds the post of Distinguished Professor at a number of universities including Cairo University, Moscow State University and Guangzhou University.Dr. Hart has been elected a fellow of the Gerontological Society of America, American College of Toxicology (where he served as president in 1981), the Association of Clinical Scientists, and the American Association for the Advancement of Science.Dr. Hart and his scientific achievements have been featured in a number of popularized books, magazines and television specials.
  
  Dr. Hart founded and managed, at The Ohio State University, what became one of the largest internationally recognized research complexes in that institution's history with competitive research grants totaling over $7 million.As Director of the National Center for Toxicological Research (NCTR) Dr. Hart developed and instituted innovative management methods.Under his leadership, the research output of NCTR increased while the facility overhead decreased.During the same period, NCTR enjoyed enhanced credibility and recognition in the scientific community.As a result of his management initiatives, Dr. Hart received a number of awards including a Presidential citation.Additional endorsement of Dr. Hart's management abilities has come from the private sector including recognition by the American Industrial Research Association, the Grace Commission Report and others.In addition to his scientific and governmental accomplishments, Dr. Hart has served on the board of directors of a number of companies including: Telescan, Inc. (a Paul Allen company), Wireless Services, Inc. (a Steve Wood company), First Commercial Bank, Little Rock, AR, e-School Solutions, and Mindography, Inc..He was one of the initial board members of Telescan, Inc., a co-founder of FarCountries.com and serves on the Advisory Board of VoiceNet, Inc, WaterChef, Inc., as well as others.
  
  Dr. Hart was co-founder and first chair of the board of directors for the Arkansas Science and Technology Authority, an author of the Federal Technology Transfer Act of 1986, chair of the US-USSR Emerging Leaders Conference, Science and Technology Section, 1988, first co-chair of the Intergovernmental Task Force on Technology Transfer in 1988, and in 1991, he and Hillary Rodham Clinton conceived the concept of a regional science and technology residential high school for Arkansas.Dr. Hart received recognition from President Ronald Regan, President (then Governor) Bill Clinton and President Mohamed Mubarak for his visionary efforts.His views on the management of science, creative deployment of scientific resources, management of technology-based industries, and the training/re-training of workers are highly solicited for publication, as keynote addresses, and in the formulation of public and private policies.
  
  Due to Dr. Harts' accomplishments, he is frequently asked to serve in the role of mediator and consensus-builder.In this capacity, he served as chair of the White House Office of Science and Technology Policy's (OSTP) Task Force on Chemical Carcinogens, the OSTP's Formaldehyde Task Force the Domestic Policy Council's Agent Orange Science Panel, the PHS's Committee to Coordinate Environmental Health and Related Programs, the Food and Drug Administration's Red Dye Number Three Panel, the FDA's Color Additive Committee, the Foundation of the Arkansas School for Math and Science.He received his Ph.D. from the University of Illinois in 1971.

• 
  www.newsherald.com/articles/administration-76191-thomps - [Cached Version]
  Published on: 7/29/2009    Last Visited: 7/29/2009  

  RON HART: College professor gets it right: Social Studies in Econ class

• 
  utopias.love.com/page/3 - [Cached Version]
  Last Visited: 7/27/2009  

  Ron Hart: College professor gets it right

• 
  www.catechinskincare.com/NewFiles2/scientistsMovies.php - [Cached Version]
  Published on: 7/10/2007    Last Visited: 7/10/2007  

  Dr. Ronald W. Hart, Bureau Chief, U.S. Food & Drug Administration

• 
  www.spectrx.com/pressreldata.asp?PRID=357 - [Cached Version]
  Published on: 10/25/2007    Last Visited: 3/4/2008  

  The newly elected board of directors is: Ronald W. Hart, Ph.D, John E. Imhoff, M.D., Michael C. James, William E. Zachary, Jr. and Mark L. Faupel, Ph.D.

Page:  1 2 3 4 5